The global ELISA analyzers market was valued at USD 667.58 million in 2022 and it is predicted to surpass around USD 871.38 million by 2032 with a CAGR of 2.7% from 2023 to 2032.
ELISA (Enzyme-Linked Immunosorbent Assay) is a widely used diagnostic tool that allows for the detection and measurement of specific proteins and antibodies in a sample. ELISA analyzers, which are automated instruments that perform various steps of the assay, provide accurate and reproducible results. These machines are valuable in the diagnosis of diseases such as HIV, hepatitis, and cancer, as well as in research fields like immunology and drug development. ELISA analyzers come in different types, including benchtop and microplate readers, and can be customized to suit specific requirements. With the advancement in technology, ELISA assays can now be performed in portable devices, making them more accessible to people in remote and underserved areas. In May 2022, Molecular Devices, LLC has launched automated work cells for ELISA workflows, which streamline and automate the process of ELISA testing, allowing for faster and more efficient analysis of large volumes of samples.
Report Scope of the ELISA Analyzers Market
Report Coverage | Details |
Market Size in 2022 | USD 667.58 million |
Revenue Forecast by 2032 | USD 871.38 million |
Growth rate from 2023 to 2032 | CAGR of 2.7% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Covered | Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, Danaher Corporation, BioTech, Agilent Technologies, QIAGEN, and PerkinElmer Inc. |
The ELISA analyzer market is driven by the need for advancements in technology and automation in the medical diagnostics industry. A key example of this is the strategic merger of Gold Standard Diagnostics Inc. with Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH in May 2022, which has expanded the company's product portfolio to include automated ELISA analyzers. ELISA is a widely used diagnostic tool that can detect and measure specific proteins and antibodies in a sample, making it a valuable tool in the diagnosis of diseases such as HIV, hepatitis, and cancer as well as in research fields such as immunology and drug development. Automated ELISA analyzers are designed to provide accurate and reproducible results, further increasing the demand for these devices.
The market is segmented based on type, type of operations, application, end user, and region. The type segment includes optical filter ELISA analyzer and optical grating ELISA analyzers. The mode segment is segmented into automated ELISA analyzers and semi-automated analyzers. Application segment is further segmented into immunology, vaccine development, drug monitoring, and others. The end-user segment is classified into pharmaceutical and biotechnology companies, contract research organization, and diagnostic laboratories.
The ELISA (Enzyme-linked immunosorbent assay) analyzer market is growing rapidly across various regions, with North America and Europe leading the way in terms of market share. In North America, the U.S. and Canada are key players in the market, driven by the presence of a large number of research centers and pharmaceutical companies in the region. Europe, particularly the UK, Germany, France, Italy, Spain, Denmark, Sweden, and Norway, also have a strong ELISA analyzer market, due to the large number of research institutions and government funding for research in these countries. Asia Pacific, specifically Japan, China, India, Australia, Thailand, and South Korea, is also witnessing significant growth in the ELISA analyzer market, driven by increasing investments in research and development and rising prevalence of chronic diseases. Latin America, with Brazil, Mexico, and Argentina as major market players, also presents a significant growth opportunity in ELISA analyzer market.
ELISA Analyzers Market Segmentations:
By type | By Mode | By Application | By End-user |
Optical Filter Elisa Analyzer Optical Grating ELISA Analyzers |
Automated ELISA Analyzers Semi-Automated Analyzers |
Immunology Vaccine development Drug Monitoring Others |
Biotechnology Companies Pharmaceutical Companies Contract Research Organization Diagnostic Laboratories |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on ELISA Analyzers Market
5.1. COVID-19 Landscape: ELISA Analyzers Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global ELISA Analyzers Market, By Type
8.1. ELISA Analyzers Market, by Type, 2023-2032
8.1.1. Optical Filter Elisa Analyzer
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Optical Grating ELISA Analyzers
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global ELISA Analyzers Market, By Mode
9.1. ELISA Analyzers Market, by Mode, 2023-2032
9.1.1. Automated ELISA Analyzers
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Semi-Automated Analyzers
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global ELISA Analyzers Market, By Application
10.1. ELISA Analyzers Market, by Application, 2023-2032
10.1.1. Immunology
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Vaccine development
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Drug Monitoring
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global ELISA Analyzers Market, By End-user
11.1. ELISA Analyzers Market, by End-user, 2023-2032
11.1.1. Biotechnology Companies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Pharmaceutical Companies
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Contract Research Organization
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Diagnostic Laboratories
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global ELISA Analyzers Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2020-2032)
12.1.2. Market Revenue and Forecast, by Mode (2020-2032)
12.1.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Forecast, by End-user (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Mode (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End-user (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Mode (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End-user (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.2. Market Revenue and Forecast, by Mode (2020-2032)
12.2.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Forecast, by End-user (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Mode (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End-user (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Mode (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End-user (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Mode (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End-user (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Mode (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End-user (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.2. Market Revenue and Forecast, by Mode (2020-2032)
12.3.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Forecast, by End-user (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Mode (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End-user (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Mode (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End-user (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Mode (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End-user (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Mode (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End-user (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.2. Market Revenue and Forecast, by Mode (2020-2032)
12.4.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Forecast, by End-user (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Mode (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End-user (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Mode (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End-user (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Mode (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End-user (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Mode (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End-user (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.5.2. Market Revenue and Forecast, by Mode (2020-2032)
12.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Forecast, by End-user (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Mode (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End-user (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Mode (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End-user (2020-2032)
Chapter 13. Company Profiles
13.1. Thermo Fisher Scientific
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Abcam
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Bio-Rad Laboratories
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Merck KGaA
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. F. Hoffmann-La Roche Ltd
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Danaher Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. BioTech
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Agilent Technologies
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. QIAGEN
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. PerkinElmer Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms